معرفی
David Seifer, MD, is a Professor of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine and Fellowship Director of Reproductive Endocrinology & Infertility. He specializes in fertility preservation, ovarian aging mechanisms, and addressing healthcare disparities in assisted reproductive technology (ART). His research led to the clinical use of Anti-Müllerian Hormone (AMH) as a diagnostic tool for ovarian reserve.
Education: MD from University of Illinois at Chicago (1981).
Research Interests: Focuses on ovarian aging, AMH biomarker development, vitamin D's role in reproductive health, and racial/ethnic disparities in IVF outcomes. His work bridges basic science (neurotrophins in oocyte maturation) and clinical applications (optimizing fertility treatments).
Article Trends: Recent work emphasizes reducing racial disparities in ART access and outcomes, optimizing IVF protocols for advanced maternal age, and understanding AMH's predictive role in aneuploidy and live birth rates.
Awards: Connecticut Top Docs (2021-2025), ASRM Star Award (annual since 2017), and recognition as one of America’s Top Doctors by Castle Connolly for two decades. Received the Ferring Innovation Grant for advancing equity in reproductive health (2021).
Advising & Grants: Mentors Yale REI fellows and leads initiatives to improve training in reproductive medicine. Active in policy advocacy for equitable ART insurance coverage.
Labs/Teams: Directs the Yale Reproductive Medicine lab, collaborating on projects like neurotrophin signaling in follicular development and vitamin D's impact on PCOS.
